Tadtong, S.; Chatsumpun, N.; Sritularak, B.; Jongbunprasert, V.; Ploypradith, P.; Likhitwitayawuid, K. Effects of Oxyresveratrol and its Derivatives on Cultured P19-derived Neurons. Trop. J. Pharm. Res. 2016, 15, 2619–2628.

28 Dec 2016
0
0

Tadtong, S.; Chatsumpun, N.; Sritularak, B.; Jongbunprasert, V.; Ploypradith, P.; Likhitwitayawuid, K. Effects of Oxyresveratrol and its Derivatives on Cultured P19-derived Neurons. Trop. J. Pharm. Res. 2016, 15, 2619–2628.

Tags

Share this

Related Posts

Regulation by SoxR of mfsA, Which Encodes a Major Facilitator Protein Involved in Paraquat Resistance in Stenotrophomonas maltophilia. Srijaruskul K, Charoenlap N, Namchaiw P, Chattrakarn S, Giengkam S, Mongkolsuk S, Vattanaviboon P. PLoS One. 2015 Apr 27;10(4):e0123699. doi: 10.1371/journal.pone.0123699.
28 Dec 2015
0

Regulation by SoxR of mfsA, Which Encodes a Major Facilitator Protein Involved in Paraquat Resistance in Stenotrophomonas maltophilia. Srijaruskul K, Charoenlap N, Namchaiw P, Chattrakarn S, Giengkam S, Mongkolsuk S, Vattanaviboon P. PLoS One. 2015 Apr 27;10(4):e0123699. doi: 10.1371/journal.pone.0123699.

Regulation by SoxR of mfsA, Which Encodes a Major Facilitator Protein Involved in Paraquat Resistance inStenotrophomonas maltophilia. Srijaruskul K, Charoenlap N, Namchaiw P, Chattrakarn S, Giengkam S,Mongkolsuk S, Vattanaviboon P. PLoS One. 2015 Apr 27;10(4):e0123699. doi: 10.1371/journal.pone.0123699.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New
20 Sep 2023
0
New

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More